Vaxcyte
PCVX
PCVX
320 hedge funds and large institutions have $11.5B invested in Vaxcyte in 2024 Q4 according to their latest regulatory filings, with 62 funds opening new positions, 138 increasing their positions, 88 reducing their positions, and 62 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 325 → 320 (-5)
25% less capital invested
Capital invested by funds: $15.5B → $11.5B (-$3.94B)
48% less funds holding in top 10
Funds holding in top 10: 23 → 12 (-11)
Holders
320
Holding in Top 10
12
Calls
$48.1M
Puts
$25.7M
Top Buyers
| 1 | +$178M | |
| 2 | +$107M | |
| 3 | +$106M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$92.8M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
+$67.7M |
Top Sellers
| 1 | -$251M | |
| 2 | -$222M | |
| 3 | -$97.7M | |
| 4 |
FAM
Fred Alger Management
New York
|
-$59M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$47.1M |